If NASCOBAL is used for the treatment of anemia concomitantly with chloramphenicol, monitor for reduced efficacy and if needed, consider an alternative therapy Risk Summary The limited available data on NASCOBAL in pregnant women are insufficient to inform a drug-associated risk of adverse developmental outcomes
If results plateau, consider cycling
Reconstitution and handling GHK-Cu is supplied as a lyophilised peptide and should be reconstituted using appropriate laboratory procedures suitable for peptide research
They recognize that clinical trials showed modest effects (average 2.6 kg over 12 weeks in responders), appreciate that individual response varies significantly, commit to proper nutrition and exercise foundations, and accept that the peptide is used for research purposes under medical supervision
Treatments are subject to provider consultation and medical eligibility.
To get the most from your glutathione supplement, here is what you need to know- glutathione can be a delicate substance, and taking it the wrong way can diminish its benefits